Cvs Therapeutic Menthol Gel

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided.

Uses and Indications

This drug is indicated for the temporary relief of minor pains associated with muscles and joints, including but not limited to simple backache, arthritis, and sprains, strains, or bruises.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the affected area should be cleaned thoroughly prior to application. The medication should be applied liberally to the affected area, not exceeding 3 to 4 times daily. There is no need for a protective cover after application.

The medication may be used in conjunction with ice packs to enhance its effects. Additionally, it can be applied with either wet or dry bandages; however, it is important to wrap the bandage loosely to avoid constriction.

For children under 2 years of age, it is advised to consult a physician before use.

Contraindications

The product is contraindicated for internal use, particularly in conjunction with heating pads or devices, as well as on wounds or damaged skin. These restrictions are in place to prevent potential adverse effects associated with improper application.

Warnings and Precautions

For external use only; contact with eyes should be avoided. This product is not intended for internal use and should not be applied in conjunction with heating pads or other devices, nor should it be used on wounds or damaged skin. It is imperative that the product is used strictly as directed. Bandaging should not be done tightly, and care must be taken to prevent contact with eyes and mucous membranes.

In the event of accidental ingestion, immediate medical assistance should be sought, or a Poison Control Center should be contacted without delay.

Patients with sensitive skin are advised to consult their healthcare provider prior to use. If any adverse reactions occur, the use of the product should be discontinued, and the healthcare provider should be notified promptly.

Side Effects

Patients should be advised that the product is for external use only and must be kept away from the eyes to prevent irritation or injury.

In addition, it is recommended that individuals with sensitive skin consult a healthcare professional prior to use to ensure safety and minimize the risk of adverse reactions.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Therapeutic Menthol Gel (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older should have their skin cleaned thoroughly before applying the medication liberally to the affected area. The application should not exceed 3-4 times daily, and no protective cover is necessary. For children under 2 years of age, it is advised to consult a doctor prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers should consider individual circumstances and the specific health needs of the patient when making recommendations.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with reduced kidney function. Regular monitoring of renal function may be warranted in these patients, although specific guidelines are not outlined.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product internally, with heating pads, or on wounds or damaged skin. It is essential to use the product only as directed, avoiding tight bandaging, and to prevent contact with the eyes and mucous membranes.

Additionally, healthcare providers should encourage patients to consult their doctor before using the product if they have sensitive skin. This precaution is important to ensure safe and effective use.

Storage and Handling

The product is supplied in a tightly sealed container to ensure integrity and stability. It should be stored at a temperature range of 59°F to 86°F (15°C to 30°C). It is essential to keep the container tightly closed when not in use to prevent contamination. Additionally, the product must not be used, poured, spilled, or stored near heat sources or open flames to maintain safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of 3-4 times daily for adults and children aged 2 years and older. Clinicians should advise patients to apply the medication liberally to the affected area.

Patients who are pregnant or breastfeeding should consult a healthcare professional prior to use. It is important to keep the product out of reach of children, and in the event of accidental ingestion, medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Cvs Therapeutic Menthol Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)